| Literature DB >> 28655773 |
Sanming Li1,2,3, Jing Zhou1,2,3, Jinghua Bu1,2,3, Ke Ning1,2,3, Liying Zhang1,2,3, Juan Li1,2,3, Yuli Guo1,2,3, Xin He1,2,3, Hui He1,2,3, Xiaoxin Cai1,2,3, Yongxiong Chen1,2,3, Peter Sol Reinach4, Zuguo Liu1,2,3,5, Wei Li6,2,3,5.
Abstract
The EDA gene encodes ectodysplasin A (Eda), which if mutated causes X-linked hypohidrotic ectodermal dysplasia (XLHED) disease in humans. Ocular surface changes occur in XLHED patients whereas its underlying mechanism remains elusive. In this study, we found Eda was highly expressed in meibomian glands, and it was detected in human tears but not serum. Corneal epithelial integrity was defective and the thickness was reduced in the early postnatal stage of Eda mutant Tabby mice. Corneal epithelial cell proliferation decreased and the epithelial wound healing was delayed in Tabby mice, whereas it was restored by exogenous Eda. Eda exposure promoted mouse corneal epithelial wound healing during organ culture, whereas scratch wound assay showed that it did not affect human corneal epithelial cell line migration. Epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) were down-regulated in Tabby mice corneal epithelium. Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR, and p-ERK in human corneal epithelial cells in a dose-dependent manner. In conclusion, Eda protein can be secreted from meibomian glands and promotes corneal epithelial cell proliferation through regulation of the EGFR signaling pathway. Eda release into the tears plays an essential role in the maintenance of corneal epithelial homeostasis.Entities:
Keywords: EDA; Ectodysplasin A; cell proliferation; cornea; epidermal growth factor receptor (EGFR); epithelial cell; genetic disease; meibomian gland dysfunction
Mesh:
Substances:
Year: 2017 PMID: 28655773 PMCID: PMC5555198 DOI: 10.1074/jbc.M117.803809
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157